These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16517094

  • 21. An eight-year experience of HDR brachytherapy boost for localized prostate cancer: biopsy and PSA outcome.
    Bachand F, Martin AG, Beaulieu L, Harel F, Vigneault E.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):679-84. PubMed ID: 18963537
    [Abstract] [Full Text] [Related]

  • 22. Potential of magnetic resonance spectroscopic imaging in predicting absence of prostate cancer in men with serum prostate-specific antigen between 4 and 10 ng/ml: a follow-up study.
    Kumar R, Nayyar R, Kumar V, Gupta NP, Hemal AK, Jagannathan NR, Dattagupta S, Thulkar S.
    Urology; 2008 Oct 01; 72(4):859-63. PubMed ID: 18329078
    [Abstract] [Full Text] [Related]

  • 23. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.
    Jereczek-Fossa BA, Zerini D, Vavassori A, Fodor C, Santoro L, Minissale A, Cambria R, Cattani F, Garibaldi C, Serafini F, Matei VD, de Cobelli O, Orecchia R.
    Int J Radiat Oncol Biol Phys; 2009 May 01; 74(1):115-25. PubMed ID: 19004572
    [Abstract] [Full Text] [Related]

  • 24. Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.
    Dattoli M, Wallner K, True L, Cash J, Sorace R.
    Urology; 2007 Feb 01; 69(2):334-7. PubMed ID: 17320673
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison.
    Leborgne F, Fowler J.
    Int J Radiat Oncol Biol Phys; 2009 Aug 01; 74(5):1441-6. PubMed ID: 19395194
    [Abstract] [Full Text] [Related]

  • 32. Detection of locally recurrent prostate cancer after cryosurgery: evaluation by transrectal ultrasound, magnetic resonance imaging, and three-dimensional proton magnetic resonance spectroscopy.
    Parivar F, Hricak H, Shinohara K, Kurhanewicz J, Vigneron DB, Nelson SJ, Carroll PR.
    Urology; 1996 Oct 01; 48(4):594-9. PubMed ID: 8886066
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. External beam radiotherapy for clinically localized hormone-refractory prostate cancer: clinical significance of Nadir prostate-specific antigen value within 12 months.
    Ogawa K, Nakamura K, Sasaki T, Onishi H, Koizumi M, Shioyama Y, Araya M, Mukumoto N, Mitsumori M, Teshima T, Japanese Patterns of Care Study Working Subgroup of Prostate Cancer.
    Int J Radiat Oncol Biol Phys; 2009 Jul 01; 74(3):759-65. PubMed ID: 19327908
    [Abstract] [Full Text] [Related]

  • 36. Value of endorectal MRI and MRS in patients with elevated prostate-specific antigen levels and previous negative biopsies to localize peripheral zone tumours.
    Cirillo S, Petracchini M, Della Monica P, Gallo T, Tartaglia V, Vestita E, Ferrando U, Regge D.
    Clin Radiol; 2008 Aug 01; 63(8):871-9. PubMed ID: 18625351
    [Abstract] [Full Text] [Related]

  • 37. Relationship of biochemical outcome to percentage of positive biopsies in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
    Guzzo TJ, Levin BM, Lee R, Guo M, Chen Z, Whittington R, Tomaszewski J, Malkowicz SB.
    Urology; 2008 Apr 01; 71(4):723-7. PubMed ID: 18387401
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomes.
    Stone NN, Potters L, Davis BJ, Ciezki JP, Zelefsky MJ, Roach M, Fearn PA, Kattan MW, Stock RG.
    Int J Radiat Oncol Biol Phys; 2007 Dec 01; 69(5):1472-7. PubMed ID: 17689026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.